CTChitrali Talele

Chitrali Talele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chitrali Talele has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Optimization of Ethyl Cellulose-Based Polymeric Nanoconjugates for Delivery of Quetiapine Fumarate

    by Chitrali Talele, Payal N. Vaja

    Objective: To develop and optimize ethyl cellulose-based polymeric nanoconjugates for sustained delivery of quetiapine fumarate in order to improve its physicochemical characteristics, encapsulation efficiency, and controlled-release behavior. Methods: Ethyl cellulose-based polymeric nanoconjugates were prepared using a solvent evaporation technique. A Plackett-Burman design was employed to screen critical formulation variables, followed by Box-Behnken design for optimization. The optimized formulation was characterized for particle size, polydispersity index, zeta potential, encapsulation efficiency, morphology, and physicochemical compatibility using SEM, FTIR, and DSC. In vitro drug release and stability studies were also conducted. Results: The optimized nanoconjugates exhibited a particle size of approximately 321 nm with a low polydispersity index, indicating uniform distribution. High entrapment efficiency (~69%) was achieved. Morphological examination showed the presence of smooth-surface and spherical particles, whereas FTIR and DSC demonstrated compatibility of drugs and polymers and successful encapsulation. The formulation exhibited a biphasic pattern of drug release which is sustained up to 24 h, after initial first-order and diffusion-controlled kinetics. Stability experiments established that there was little change when standard storage conditions were used. Conclusion: The developed ethyl cellulose nanoconjugates provide an effective strategy for sustained delivery of quetiapine fumarate, improving its physicochemical and release characteristics. This system has a great potential toward increasing the therapeutic efficacy and patient compliance, which requires further in vivo and clinical research.

  • Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Mamta Kumari, Gaurav Gupta

    Introduction: This review aims to comprehensively discuss the emerging role of artificial intelligence (AI) and three-dimensional (3D) printing in the design and development of personalized polymeric nanocomposite-based drug delivery systems. The focus is on how integrating these technologies enhances the precision, efficacy, and customization of pharmacotherapy compared with conventional formulations. Methods: An extensive literature survey was conducted using databases such as PubMed, Scopus, Web of Science, and ScienceDirect, focusing on publications from the past decade. Peer-reviewed studies, reviews, and reports on polymeric nanocomposites, AI-based formulation design, and 3Dprinted drug delivery systems were critically analyzed. The collected data were synthesized to elucidate design principles, fabrication methods, and the synergistic application of AI and 3D printing in personalized medicine. Results: Polymeric nanocomposites have demonstrated superior performance in targeted and controlled drug release due to their adaptable physicochemical properties and biocompatibility. The application of AI enables predictive modeling, optimization of formulation parameters, and patient stratification through data-driven algorithms. Concurrently, 3D printing enables the fabrication of patient-specific dosage forms and implants with programmable drug-release profiles. Together, these technologies enable the development of individualized therapeutic systems that enhance treatment outcomes and minimize adverse effects. Discussion: This synergistic incorporation of AI and additive manufacturing tackles some of the main obstacles in precision medicine by diminishing trial-and-error in formulation, enhancing reproducibility, and promoting better outcomes during treatment. Such multidisciplinary applications are most promising in cancer, diabetes, neurodegenerative, infectious, and cardiovascular diseases. Conclusion: The integration of AI and 3D printing represents a transformative advancement in personalized nanocomposite drug delivery. These interdisciplinary approaches collectively enable precise control over drug release kinetics, dosage customization, and formulation design. Future developments focusing on regulatory standardization, ethical data use, and large-scale clinical translation will further accelerate the adoption of AI- and 3D-printing-assisted personalized drug delivery systems in clinical practice. While these technologies hold great potential for personalized and precise therapeutics, their clinical translation remains challenged by regulatory validation, manufacturing reproducibility, and data transparency requirements.


  • Exploring the Molecular Pathways of Tinospora cordifolia in the Management of Diabetic Foot Ulcers

    by Mamta Kumari, Piyushkumar Sadhu, Niyati Shah, Chitrali Talele, Gaurav Kant Saraogi, Shikha Sharma

    Introduction: Medicinal plants are increasingly recognized as alternative and complementary therapies, particularly in India and other Asian countries. Tinospora cordifolia (Giloy/Guduchi) is a well-known medicinal plant with extensive therapeutic applications, including immune modulation, antidiabetic, anti-inflammatory, antioxidant, and antimicrobial effects. Given these properties, T. cordifolia shows promise for managing Diabetic Foot Ulcers (DFUs), a severe complication of diabetes associated with infection and the risk of amputation. Methods: This review compiles and critically analyzes the published literature on T. cordifolia, focusing on its phytochemical composition, pharmacological activities, and therapeutic relevance to diabetic foot ulcers. Data were gathered from PubMed, Scopus, Web of Science, and Google Scholar, including experimental, preclinical, and clinical studies describing its bioactive constituents and mechanisms related to immune regulation and wound healing Results: Bioactive compounds such as alkaloids, diterpenoids, and polysaccharides derived from the stem, root, and whole plant exhibit significant immunomodulatory, anti-inflammatory, antioxidant, and antibacterial activities. These properties collectively support enhanced wound healing, infection control, and immune regulation, indicating the potential effectiveness of T. cordifolia in the treatment of DFU. Its favorable physiological compatibility and minimal side effects further strengthen its therapeutic value. Discussion: The multifaceted pharmacological actions of T. cordifolia align well with the complex pathophysiology of diabetic foot ulcers, which involves impaired immunity, chronic inflammation, oxidative stress, and microbial infection. The plant’s immune-modulating and wound-healing effects suggest its usefulness as an adjunct to conventional DFU therapies. However, mechanistic insights and standardized clinical evidence remain limited. Conclusion: Tinospora cordifolia represents a promising adjunctive therapeutic option for the management of diabetic foot ulcers. Future research should emphasize detailed biochemical mechanisms, synergistic effects with conventional drugs or other herbs, and well-designed clinical trials. Its incorporation into nutraceuticals and dietary supplements may further aid in chronic disease management and immune enhancement, bridging traditional knowledge with modern therapeutic strategies.

  • Open Access

    Polymeric design strategies in chitosan-based biomaterials for periodontal applications

    by Chitrali Talele, Chintan Aundhia, Dipali Talele, Piyushkumar Sadhu, Manisha Lalan, Gaurav Gupta


  • Nanostructured Polymer Scaffolds in Local Chemotherapy in Solid Tumors

    by Chitrali Talele, Chintan Aundhia, Dipali Talele, Niyati Shah, Mamta Kumari, Manisha Lalan, Shrikaant Kulkarni

    Introduction: Multidrug resistance, inadequate tumor penetration, and systemic toxicity significantly limit the effectiveness of conventional chemotherapy in solid tumors. Scaffold-based localized chemotherapy offers a promising approach to overcome these challenges by delivering drugs directly to the tumor site with sustained and controlled release. Methods: This article reviews electrospun nanofiber scaffolds, injectable hydrogels, 3D-printed scaffolds, and composite biomaterial scaffolds engineered from biodegradable and bioresponsive polymers such as PLGA, PCL, chitosan, and hyaluronic acid. The influence of drug incorporation strategies, including surface loading, encapsulation, and post-fabrication soaking, on drug loading capacity, degradation behavior, mechanical strength, and release kinetics is examined. Results: Preclinical studies in breast cancer, glioblastoma, colorectal cancer, and pancreatic cancer demonstrate that scaffold-based systems increase local drug concentration, reduce systemic toxicity, and improve therapeutic outcomes. Advanced systems such as dual-drug platforms, stimuliresponsive constructs, and immunomodulatory scaffolds show additional potential to modulate the tumor microenvironment, prevent recurrence, and enhance antitumor immune responses. Moreover, technologies such as electrospinning are well established, whereas advanced modalities like 4D bioprinting remain in early developmental stages, limiting their current translational readiness. Discussion: The application of scaffolds in cancer therapy highlights their theranostic potential, combining controlled chemotherapeutic delivery with capabilities for tissue support, microenvironment modulation, and functional integration with biological systems. Conclusion: Nanostructured polymer scaffolds represent a promising strategy for localized chemotherapy in solid tumors. By overcoming key limitations of systemic drug delivery, these platforms enhance treatment precision, improve patient outcomes, and demonstrate strong translational potential for next-generation oncology therapeutics.

  • Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Permeation in Neurological Drug Delivery

    by Chitrali Talele, Chintan Aundhia, Dipali Talele, Niyati Shah, Mamta Kumari, Piyushkumar Sadhu

    The blood-brain barrier (BBB) serves as a formidable obstacle to the treatment of neurological disorders by restricting the passage of therapeutic agents into the central nervous system (CNS). Polymeric nanocarriers have emerged as innovative tools to enhance drug delivery across the BBB, improving the bioavailability and efficacy of treatments for various neurological diseases. This review explores the challenges associated with BBB permeability and highlights recent advances in polymeric nanocarrier design. Key strategies such as surface modification, ligand conjugation, and stimuli-responsive carriers are discussed to optimize BBB penetration. Furthermore, this review examines the therapeutic potential of nanocarrier-based approaches for treating neurodegenerative disorders, brain tumors, and stroke. By leveraging nanotechnology, polymeric nanocarriers offer a promising avenue to overcome BBB-related drug delivery limitations and advance CNS therapeutics.


  • Impact and Significance of Viral Vectors for siRNA Delivery in the Treatment of Alzheimer’s Disease

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Rahul Trivedi, Mamta Kumari, Jay Chudasama

    Alzheimer’s disease (AD) remains a major challenge in developing effective treatments due to its complex pathophysiology, including the accumulation of amyloid-beta plaques and tau tangles. Small interfering RNA (siRNA) technology offers promise for targeted gene silencing, but effective delivery to the central nervous system remains a significant obstacle. Viral vectors have emerged as potent delivery vehicles for transporting siRNA to neural tissues. This review explores the utilization of viral vectors for siRNA delivery in AD, focusing on delivery strategies and challenges. We discuss the design and optimization of viral vectors, targeting strategies, and safety considerations. Additionally, we examine recent advancements and prospects for enhancing viral vector-mediated siRNA delivery in AD.


  • Polymeric Nanocarriers with pH-Dependent Release for Tumor-Specific Delivery

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Piyushkumar Sadhu, Avinshkumar Seth

    The acidic nature of tumor microenvironments presents a unique opportunity for the targeted delivery of therapeutics using pH-responsive polymeric nanocarriers. These smart nanocarriers are designed to release their payload specifically in response to the low pH found in tumor tissues, thereby enhancing drug accumulation at the tumor site while minimizing systemic side effects. This review provides a comprehensive overview of the design principles, fabrication methods, and applications of pH-responsive polymeric nanocarriers for targeted drug delivery in tumor microenvironments. Key topics include the mechanisms of pH-responsive drug release, engineering strategies for developing pH-sensitive polymers, and recent advancements in exploiting tumor acidity for improved therapeutic outcomes. Additionally, the review discusses the clinical potential and the challenges associated with the translation of these nanocarriers from bench to bedside.


  • Design and development of leflunomide loaded topical microsponge gel: insights from ex vivo and in vivo inflammatory studies

    by Nirmal Shah, Priyank Patel, Dipti Gohil, Rajesh Maheshwari, Chitrali Talele, Dipali Talele, Dhaivat Parikh, Jay Patwa

    Leflunomide, a frequently used medicament, falls under the category of disease modifying anti-rheumatoid drugs. The tablets are the only product available in the market which may lead to liver toxicity upon long term use. Being a class II drug, there is a need of some novel formulation for minimizing systemic toxicity of drug without compromising its therapeutic potential. Microsponges possess unique characteristics that makes it a versatile drug delivery carrier. Leflunomide loaded Microsponges were prepared with matrix forming polymer (ethyl cellulose) and stabilizer (poly vinyl alcohol) using quasi emulsion solvent diffusion method. Two independent parameters, namely concentrations of polymer and stabilizing agent, were examined using a full 32 factorial design to determine their impact on particle size and % entrapment efficiency. The optimized formulation showed promising result for particle size (48.96µm) and entrapment efficiency (89.45%) with spherical and tiny pores on surface. The optimized gel exhibited sustained release up to 8 h (91.46 ± 3.84%) with satisfactory results of flux and permeability coefficient. The developed formulation has good anti-inflammatory properties in wistar rats and a histopathology investigation on rats' skin verified its skin compatibility. The stability study showed stable formulation up to the period of three months. These findings demonstrated the potential of microsponges to improve the therapeutic potential of poorly soluble leflunomide.